In another major study about the spectrum and prognostic relevance of driver gene mutations in AML, IDH2 mutations were not found to be associated with NPM1 mutations and only IDH1 mutations was weakly pair wise associated with FLT3-ITD (Metzeler et al., 2016). The gene discussed is IDH1; the disease is acute myeloid leukemia.